ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,019.85
-0.31%
Dow Jones
37,933.16
0.31%
US Dollar vs MXN
17.0333
-0.70%
Brent Oil
83.605
-2.67%
Bitcoin
56,940.70
-6.04%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Intercept Pharmaceuticals Inc (ICPT)

  7. Intercept Pharmaceuticals Inc (ICPT) Noticias

ICPT Intercept Pharmaceuticals Inc

19.00
0.00 (0.00%)
Última actualización: 19:00:00
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Intercept Pharmaceuticals Inc ICPT NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 19.00 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
19.00
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
29/2/202407:30GLOBEIntercept Announces FDA Acceptance of Supplemental New Drug..
20/11/202311:09EDGAR2Form 15-12G - Securities registration termination [Section..
14/11/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
13/11/202313:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202313:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202313:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202313:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202313:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202313:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202313:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202313:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202313:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202313:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202313:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202313:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202313:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202313:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202313:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202307:00GLOBEIntercept Announces New Phase 2 Data Showing Significant..
10/11/202307:00GLOBEIntercept Announces New Findings from Long-term Extension of..
08/11/202315:44EDGAR2Form 8-K - Current report
08/11/202315:28EDGAR2Form POS AM - Post-Effective amendments for registration..
08/11/202315:21EDGAR2Form S-8 POS - Securities to be offered to employees in..
08/11/202308:21EDGAR2Form 25-NSE - Notification filed by national security..
08/11/202308:13GLOBEAlfasigma completes acquisition of Intercept..
08/11/202306:50EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
08/11/202305:04EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
06/11/202316:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202315:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202308:10EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
30/10/202307:49EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
26/10/202308:07EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
26/10/202307:54EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
18/10/202308:02EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
17/10/202316:12EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
11/10/202315:34EDGAR2Form SC 14D9 - Solicitation, recommendation statements
11/10/202315:16EDGAR2Form SC TO-T - Tender offer statement by Third Party
10/10/202310:10EDGAR2Form SC TO-C - Written communication relating to an issuer..
28/9/202316:17EDGAR2Form SC14D9C - Written communication relating to third party..
26/9/202316:06EDGAR2Form SC14D9C - Written communication relating to third party..
26/9/202311:43EDGAR2Form SC TO-C - Written communication relating to an issuer..
26/9/202307:28EDGAR2Form 8-K - Current report
26/9/202307:00GLOBEAlfasigma to Acquire Intercept Pharmaceuticals for $19.00..
25/9/202315:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202315:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202307:30GLOBEIntercept Pharmaceuticals to Conduct Fireside Chats and..
03/8/202315:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/8/202315:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/8/202306:05EDGAR2Form 8-K - Current report
02/8/202306:00GLOBEIntercept Pharmaceuticals Reports Second Quarter 2023..

Su Consulta Reciente

NASDAQ
ICPT
Intercept Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados